1,351
Views
10
CrossRef citations to date
0
Altmetric
Research Article

A Nordic survey on the management of head and neck CUP

, &
Pages 1159-1163 | Received 10 Apr 2016, Accepted 03 May 2016, Published online: 16 Jun 2016

References

  • de Bree R. The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour. Eur Arch Otorhinolaryngol 2010;267:1653–5.
  • Waltonen JD, Ozer E, Hall NC, Schuller DE, Agrawal A. Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup. Arch Otolaryngol Head Neck Surg 2009;135:1024–9.
  • Dragan AD, Nixon IJ, Guerrero-Urbano MT, Oakley R, Jeannon JP, Simo R. Selective neck dissection as a therapeutic option in management of squamous cell carcinoma of unknown primary. Eur Arch Otorhinolaryngol 2014;271:1249–56.
  • Jensen DH, Hedback N, Specht L, Hogdall E, Andersen E, Therkildsen MH, et al. Human papillomavirus in head and neck squamous cell carcinoma of unknown primary is a common event and a strong predictor of survival. PLoS One 2014;9:e110456.
  • Yasui T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, et al. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin. PLoS One 2014;9:e95364.
  • Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Rev 2004;30:153–64.
  • Issing WJ, Taleban B, Tauber S. Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol 2003;260:436–43.
  • Chen AM, Marsano J, Perks J, Farwell G, Luu Q, Donald PJ, et al. Comparison of IMRT techniques in the radiotherapeutic management of head and neck cancer: is tomotherapy “better” than step-and-shoot IMRT? Technol Cancer Res Treat 2011;10:171–7.
  • Mistry RC, Qureshi SS, Talole SD, Deshmukh S. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary: outcomes and patterns of failure. Indian J Cancer 2008;45:54–8.
  • Sun R, Tang X, Yang Y, Zhang C. (18)FDG-PET/CT for the detection of regional nodal metastasis in patients with head and neck cancer: a meta-analysis. Oral Oncol 2015;51:314–20.
  • Mohindra S, Bhattacharya A, Goshal S, Gupta B. Incremental (?) role of positron emission tomography/computed tomography in clinically unknown primary patients with neck metastasis. Indian J Cancer 2014;51:142–4.
  • Johansen J, Petersen H, Godballe C, Loft A, Grau C. FDG-PET/CT for detection of the unknown primary head and neck tumor. Q J Nucl Med Mol Imaging 2011;55:500–8.
  • Karni RJ, Rich JT, Sinha P, Haughey BH. Transoral laser microsurgery: a new approach for unknown primaries of the head and neck. Laryngoscope 2011;121:1194–201.
  • Koivunen P, Back L, Laranne J, Irjala H. Unknown primary: diagnostic issues in the biological endoscopy and positron emission tomography scan era. Curr Opin Otolaryngol Head Neck Surg 2015;23:121–6.
  • Nguyen NP, Vos P, Lee H, Borok TL, Karlsson U, Martinez T, et al. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer. Oncology 2008;75:186–91.
  • Shoushtari A, Saylor D, Kerr KL, Sheng K, Thomas C, Jameson M, et al. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy. Int. J Radiat Oncol Biol Phys 2011;81:e83–91.
  • Cuaron J, Rao S, Wolden S, Zelefsky M, Schupak K, Mychalczak B, et al. Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy. Head Neck 2016;38:E426–31.
  • Chen AM, Farwell DG, Lau DH, Li BQ, Luu Q, Donald PJ. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio? Int J Radiat Oncol Biol Phys 2011;81:346–52.